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Abstract
On 22 June 2005 the Senate of the Commonwealth of Australia voted to establish an inquiry into
workplace harm related to toxic dust and emerging technologies (including nanoparticles). The
inquiry became known as the "White" Inquiry after Mr Richard White, a financially uncompensated
sufferer of industrial sandblasting-induced lung disease who was instrumental in its establishment.
The "White" Inquiry delivered its final report and recommendations on 31 May 2006. This paper
examines whether these recommendations and their implementation may provide a unique
opportunity not only to modernize relevant monitoring standards and processes, but related
compensation systems for disease associated with workplace-related exposure to toxic dusts. It
critically analyzes the likely role of the new Australian Safety and Compensation Council (ASCC)
in this area. It also considers whether recommendations related to potential workplace related
harm from exposure to nanoparticles could commence a major shift in Australian healthcare
regulation.
Background
On 22 June 2005 the Senate of the Commonwealth of
Australia voted to establish an inquiry into workplace
harm related to toxic dust and emerging technologies
(including nanoparticles). The inquiry has become
known as the "White" Inquiry after Mr Richard White, a
financially uncompensated sufferer of industrial sand-
blasting-induced lung disease whose sentinel case and
advocacy through the Australian Sandblasting Diseases
Coalition (ASDC) was instrumental in its establishment.
Its final report was delivered on 31 May 2006 [1].
Numerous government inquiries into toxic dust exposure
in Australia have been held since the turn of the century.
They have focused, for example, on worker health prob-
lems associated with the Western Australia and Victorian
goldmines and NSW and Queensland coalmines, as well
as the Sydney sandstone industries (through the NSW Sili-
cosis Board (now the Dust Diseases Board)) [2]. In 1993,
the National Occupational Health and Safety Commis-
sion reviewed the occupational exposure standard for
crystalline silica (silicon dioxide (SiO2) chiefly from abra-
sive blasting, excavating, quarrying or tunneling quartz
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concrete and stone)[3].
There are, however, many reasons to consider that the
level of disease associated with workplace disease from
toxic dust continues to be much greater than revealed by
such inquiries or reviews. First, the long latency period of
the relevant diseases and the insidious nature of their
acquisition, mean that the actual incidence and preva-
lence of workplace injury from toxic dusts remains largely
unknown. Second, it remains unclear what exposure lev-
els (mg/m3) effectively minimize injury[4]. Occupational
exposure limits for crystalline silica, for example, are
almost constantly under review worldwide because of the
large numbers of exposed people[5]. The position is fur-
ther complicated because accurate exposure monitoring
and hence enforcement of standards, is generally more
difficult at lower exposure levels[6].
Third, associated cigarette smoking often complicates cau-
sation analysis in workers regularly exposed to toxic
dusts[7]. This is particularly true where the disease mani-
festation is lung cancer [8] and many potentially carcino-
genic compounds are used in the workplace[9]. Fourth,
many workers suffering disease associated with exposure
to toxic dusts during employment will not seek, let alone
receive compensation[10]. Fifth, the infrastructure for suc-
cessful implementation of national standards (including
the number of occupational hygenists in government
employment) has been eroded and few if any Australian
companies have been prosecuted for exposing workers to
the risk of dust-related disease [2].
A sentinel case highlighting such problems was provided
by Mr Richard White.
Richard White's silicosis: a sentinel case for 
policy change
As a teenager, Mr Richard White was employed, between
1971 and 1974 in the Northern Territory, to sandblast
clean barges and fuel tanks, then spray them with an
epoxy resin containing many of the carcinogens listed
above. He did this without being issued respiratory pro-
tection. In the 1990's, Mr White began to notice severe
dyspnoea, fatigue, paroxysmal coughing and sputum pro-
duction, particularly when playing with his children. He
suffered repeated chest infections and initiated a compen-
sation claim in the Northern Territory Supreme Court.
This alleged that as a result of this employment, he had
developed silicosis and/or emphysema and/or chronic air
flow limitation[11]. He was initially met with legal
defence arguments about the liability of subsidiary com-
panies, similar to those raised in the James Hardie asbes-
tos litigation[12]. It is a matter of record that Mr White
lost the first instance trial, the subsequent appeal to the
Supreme Court of the Northern Territory and an appeal to
the High Court of Australia. His history of mild smoking
(reported as < 5 pack years) was a significant factor in the
case against him, as was a defence-proffered allegation of
asthma, for which there was no known medical history
[13].
The histopathology of Mr White's subsequent open lung
biopsy, revealed, as well as some adjacent emphysema:
"Scant brightly birefringent, needle-shaped crystalline mate-
rial, consistent with inhaled silicate crystals, are noted within
these macrophages. In addition, similar material is noted in
macrophages within the lymphoid aggregates of the dust sumps,
with a miniscule amount of associated interstitial fibrosis".
These results strongly suggested Mr White had industri-
ally-related silica injury to his lungs, in the form of inter-
stitial fibrosis, small airways disease and emphysema,
giving rise to mainly fixed airflow obstruction. Mr White
thereafter placed a newspaper advertisement. It requested
people to contact him who knew or suspected they had
acquired lung or other disease through working for com-
panies that used sandblasting techniques. By Christmas
2004, Mr White had obtained almost a thousand
names[13].
Many of these people claimed to have experienced symp-
toms consistent with debilitating lung diseases or cancer
related to workplace exposure to toxic dusts. Very few had
received or sought any compensation. Given the relatively
informal way in which the list was been prepared, Mr
White began to believe that many other Australians has
suffered potentially harmful exposure to toxic workplace
dust, without ever seeking more specific diagnosis or
financial compensation[13].
Mr White and the first author commenced lobbying for a
Senate Inquiry into the workplace risks of toxic dusts in
Australia as the best way to initiate a change in health pol-
icy in this area. Late in June 2005 Senators Lyn Allison
(Dem.) and Gary Humphries (Lib.) successfully obtained
the majority required to initiate that Inquiry. Its terms of
reference were expanded to include the potential of
emerging technologies, including nanoparticles, to result
in workplace related harm.[14] The recommendations of
the "White" Senate Inquiry urge the new Australian Safety
and Compensation Council (ASCC) toward some far-
reaching changes in the system of prevention and moni-
toring of dust-related disease in Australia.
Policy recommendations for general workplace 
toxic dust exposure
Chronic Obstructive Pulmonary Disease ("COPD") is cur-
rently the fourth leading cause of death worldwide andPage 2 of 5
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developed world continues to increase. An analysis of 10
large scale studies (taking into account tobacco smoking
status) in the US, France, Spain, Norway, the Netherlands,
Italy, China and New Zealand, indicates that approxi-
mately 15% of the burden of illness from COPD arises
from workplace exposure to toxic dust[15]. This is
unlikely to be a "worst-case" estimate, rather, the studies
reveal that much COPD is undiagnosed[16]. In Australia,
recent epidemiological studies in middle aged Melbourne
residents have shown that a relatively significant amount
of COPD is not related to smoking, and industrial expo-
sures are a significant contribution[17]. There is now good
pathological evidence in both humans and animals of the
capacity of crystalline silica to cause emphysema[18]. Aus-
tralian healthcare policy and related monitoring and com-
pensation systems appear, however, not to have fully
appreciated the regulatory significance of this advance in
causal understanding.
The British Coal litigation, on the other hand, was a water-
shed in the development of clinical and legal theories
about causative relationships between industrial dust
exposure and COPD. One of its major conclusions was
that disability in a toxic dust-exposed cigarette smoker
should not be regarded for compensation purposes as if it
was entirely due to one cause or the other. Rather the
courts in that nation decided they should attempt to esti-
mate, as far as possible, the contribution of each such
cause and then award compensation proportionally[19].
A related recommendation, posing an obvious challenge
to Australian healthcare policy, was that compensation
should prima facie be paid to any worker with COPD who
has worked underground for 20 years, even in the absence
of pneumoconiosis on chest x-ray[20].
The "White" Senate Inquiry recommended that the ASCC
review the National Data Action Plan, to increase the
availability of relevant data (Rec. 1). It required the ASCC
to extend the Surveillance of Australian Work-Based Res-
piratory Events (SABRE) program Australia-wide, to pro-
vide mandatory reporting of dust-related disease (Rec. 2).
Most importantly, it required the ASCC in conjunction
with the Heads of Workplace Safety Authorities consider
mechanisms to increase the number of occupational hygi-
enists being trained and employed by regulators (Rec.8).
The Minister for Employment and Workplace Relations is
asked to raise with the Workplace Relations Ministers'
Council the need to enact nationally consistent standards
for identification, assessment and compensation for suf-
ferers and their families based on at least the standard on
the NSW Workers Compensation (Dust Diseases Act) 1942,
as well as removing restrictive statutes of limitation (Rec.
7, 9, 10 & 11)[1].
These recommendations, particularly the last, provide
strong policy opportunities for an Attorney General with
a firm interest in unifying areas of legal regulation in Aus-
tralia and a Federal government willing to display its gen-
uine concern for protecting worker safety in a period of
considerable upheaval in workplace relations. They set a
challenge for the ASCC that should be called to account
for the steps taken toward their implementation by March
2007. State governments displaying a lack of willingness
to become involved in this long overdue regulatory
rationalization should also have their credentials on
workplace safety called into question.
Policy challenges from workplace exposure to 
nanotechnology
Nanoparticles are very small. A nanometer is one-bil-
lionth of a metre (a human hair is 80,000 nm wide)[21].
Nanoparticles particularly used in transparent sunscreens
and cosmetics, "smart" surveillance equipment, fertilizers
and packaging, nutritionally enhanced foods, long-lasting
paints and as industrial catalysts. They may also arise from
thermal spraying, metal production and refining, weld-
ing, soldering and high speed metal grinding[22]. Medical
nanotechnology involves the development of drug/inva-
sive therapeutic device products controllable at atomic,
molecular or macromolecular levels of approximately 1–
100 nanometers. It is a rapidly expanding area of research
globally with revolutionary implications for disease detec-
tion and analysis,[23] drug delivery,[24] and reconstruc-
tive,[25] neurological[26] and cardiac surgery[27].
Australian companies are already working, for example,
on nanotechnology-based sunscreen, anticoagulant and
drug delivery products[28].
Nanoparticles present unique health risks, being
extremely reactive whilst readily penetrating mucosal
membranes, entering blood vessels and impacting on the
coagulation system. There are currently no effective meth-
ods to measure and assess exposure risks to nanoparticles
in patients or healthcare workers. Nanoparticle exposure
limits do not exist and manufacturers currently have no
obligation to publish details of the safety checks imposed
on their nanoproducts. A long latency period for disease
from exposure to nanoparticles and the insidious symp-
tom development, mean causation will be difficult to
legally prove and compensation difficult to obtain.[29]
Sketchy nanomedicine safety and toxicity profiles thus
may create major policy challenges, not only for Austral-
ian Therapeutic Goods Administration (TGA) marketing
approvals, but for Pharmaceutical Benefits Advisory Com-
mittee (PBAC) and Medical Services Advisory Committee
(MSAC) cost-effectiveness evaluations, as well as the hori-
zon scanning program of the Health Policy Advisory
Committee on Technology (HealthPACT). Interdepart-
mental meetings, industry consultations and discussionsPage 3 of 5
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health risks of nanotechnology generally (and will con-
tinue under the interdepartmental committee of the
National Nanotechnology Strategy Taskforce ("NNST")
within the Department of Industry, Tourism and
Resources)[30]. A 2005 report to the Prime Minister's Sci-
ence Engineering and Innovation Council warned: "The
early introduction and explanation of regulation reduces
the risk that public concern will prevent acceptance of
nanotechnology. Industry also tends to prefer certainty in
regulation"[31].
The "White" Senate Inquiry recommended that the
National Nanotechnology Strategy be finalized as a mat-
ter of priority (Rec. 12). It required establishment of a
widely consulting working party on nanotechnology reg-
ulation, comprising representatives of the Therapeutic
Goods Administration, the National Industrial Chemicals
Notification and Assessment Scheme (NICNAS), and the
ASCC. This is to consider (with consideration of interna-
tional models) the appropriateness of existing regula-
tions, how gaps and uncertainties in that regulatory
framework can be addressed and risk management incor-
porated, possible reassessment of safety and whether a
permanent nanotechnology regulatory body needs to be
established. (Rec. 12, 13 and 14)[1].
These recommendations present an opportunity for Aus-
tralia to develop an innovative and practical regulatory
framework that will not only facilitate the development of
an important industry sector, but ensure the safety of
workers and those members of the public associated with
its products. Implementing these policy recommenda-
tions becomes a matter of national urgency, given the bur-
geoning level of research already taking place in this area
in Australia.
Conclusion. Policy challenges for the ASCC
The new ASCC, replacing the National Occupational
Health and Safety Commission (NOHSC), first met on 20
October 2005. The ASCC comprises representatives from
Federal, State and Territory Governments, the Australian
Council of Trade Unions (ACTU) and the Australian
Chamber of Commerce and Industry (ACCI). One of its
main aims is to provide policy advice to the Workplace
Relations Minister's Council on OHS and workers' com-
pensation arrangements. A related purpose is to deliver
nationally consistent frameworks providing leadership
and coordination to prevent workplace death, injury and
disease through two working groups: an OHS Working
Group, and a Workers Compensation Working
Group[32].
There are many core policy challenges that the ASCC will
have to address in implementing the recommendations of
the "White" Senate Inquiry. The first is that the crucial
problem of workplace-related disease from toxic dusts,
both world-wide and in Australia, has not been one of cre-
ation of standards, but of their implementation[33].
Standards, for example, prohibiting abrasive sand blasting
and providing recommended exposure limits for respira-
ble crystalline silica, as well as respiratory protection,
worker education and regular medical examinations have
been in place in Australia since the late 1960's and early
1970's[34]. Since that time, funding has been reduced for
inspectors and insufficient attention paid to increasing
their powers. It is imperative that the ASCC give priority
to evaluating and recommending to State and Federal gov-
ernments the required numbers of occupational health
and safety inspectors capable of enforcing any new
national standards.
Second, the ASCC will need to address evidence presented
to the "White" Senate Inquiry suggesting that toxic dust
workplace exposure presents much greater health prob-
lems to the Australian community than is currently recog-
nized. Community exposure through wind-borne dust
and rainwater, for example, clearly has been insufficiently
investigated.
Third, there is currently almost no credible research on the
health impacts of nanoparticles despite increasing use of
such technology in Australian industry. This data and reg-
ulatory gap must also be filled, thoroughly and compe-
tently and after broad consultations, by the ASCC.
Fourth, the ASCC needs to prioritise streamlining (and
equity of access issues) for compensation processes linked
with best scientific practice in the understanding of dis-
ease causation. Resolution of this issue will provide an
important backdrop to implementation of existing and
improved safety standards in the area of dust-related dis-
ease.
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